US Genomics Raises $17M in Private Placement | GenomeWeb

NEW YORK, April 4 – US Genomics of Woburn, Mass., said Wednesday it has raised $17 million in private financing, which will be used to develop the company’s DNA analysis technology.

HealthCare Ventures and existing investors, including CB Health Ventures and Still River Fund, contributed to the financing round. Augustine Lawlor, general partner at HealthCare Ventures, also joined US Genomics’ board of directors.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.